Pharmacovigilance SaaS platform for drug safety and regulatory compliance
Qinecsa operates a digital pharmacovigilance platform serving pharma, biotech, and health authorities—a 18-year-old specialist competing in a heavily regulated, compliance-driven space. The engineering-heavy hiring profile (10 engineers vs. 3 design, 2 product) paired with active project work on SaaS platform development and data optimization suggests a company scaling infrastructure rather than top-line feature velocity. Pain points center on regulatory compliance, third-party integrations, and data governance—exactly the friction points that define enterprise pharma workflows.
Qinecsa is a London-based pharmacovigilance services and platform company with 1,001–5,000 employees operating globally since 2006. The business combines human expertise (multilingual call centers, clinical safety reviewers, QPPVs) with a SaaS platform (Qinecsa Vigilance Workbench) that handles ICSR preparation, signal detection, literature screening, and regulatory submissions. The customer base includes large pharma companies and national health authorities; the operational footprint spans the UK, India, Croatia, and Bulgaria. Current hiring velocity is accelerating, with 20 active roles skewed toward senior and principal engineers, reflecting investment in platform scalability and data infrastructure.
Qinecsa operates a mixed cloud environment (Azure, AWS, GCP) with Microsoft 365 for productivity, PostgreSQL and SQL Server for data, Tableau for analytics, and C#, Java, JavaScript, Ruby, and Python for application development. Security tools include CrowdStrike, Qualys, Cisco, and Fortinet.
Current priorities include Vigilance Workbench SaaS platform development, data platform optimization and cost reduction, third-party system integration, client upgrade and configuration projects, and functional impact assessments for regulatory compliance.
Other companies in the same industry, closest in size